Old Web
English
Sign In
Acemap
>
Paper
>
25996 Safety of tildrakizumab 100 mg and 200 mg through 5 years of exposure in reSURFACE 2
25996 Safety of tildrakizumab 100 mg and 200 mg through 5 years of exposure in reSURFACE 2
2021
Lorne Albrecht
George Han
Wendy Cantrell
Andrea Nguyen
Alan M. Mendelsohn
Stephen J. Rozzo
Keywords:
Medicine
Tildrakizumab
Anesthesia
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]